382 related articles for article (PubMed ID: 32709718)
1. Lysin LysMK34 of
Abdelkader K; Gutiérrez D; Grimon D; Ruas-Madiedo P; Lood C; Lavigne R; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
Appl Environ Microbiol; 2020 Sep; 86(19):. PubMed ID: 32709718
[TBL] [Abstract][Full Text] [Related]
2. Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.
Abdelkader K; Gutiérrez D; Tamés-Caunedo H; Ruas-Madiedo P; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
Appl Environ Microbiol; 2022 Jan; 88(1):e0151521. PubMed ID: 34669452
[TBL] [Abstract][Full Text] [Related]
3. Colistin-phage combinations decrease antibiotic resistance in
Wang X; Loh B; Gordillo Altamirano F; Yu Y; Hua X; Leptihn S
Emerg Microbes Infect; 2021 Dec; 10(1):2205-2219. PubMed ID: 34736365
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii.
Wintachai P; Phaonakrop N; Roytrakul S; Naknaen A; Pomwised R; Voravuthikunchai SP; Surachat K; Smith DR
Sci Rep; 2022 Feb; 12(1):2633. PubMed ID: 35173237
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
6. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
[TBL] [Abstract][Full Text] [Related]
7. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
Sun B; Liu H; Jiang Y; Shao L; Yang S; Chen D
mSphere; 2020 Apr; 5(2):. PubMed ID: 32238571
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis and Antivirulence Properties of a New Depolymerase from a Myovirus That Infects Acinetobacter baumannii Capsule K45.
Oliveira H; Costa AR; Ferreira A; Konstantinides N; Santos SB; Boon M; Noben JP; Lavigne R; Azeredo J
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463964
[No Abstract] [Full Text] [Related]
9. The Specific Capsule Depolymerase of Phage PMK34 Sensitizes
Abdelkader K; Gutiérrez D; Latka A; Boeckaerts D; Drulis-Kawa Z; Criel B; Gerstmans H; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625321
[TBL] [Abstract][Full Text] [Related]
10. Membrane-Permeable Antibacterial Enzyme against Multidrug-Resistant
Chen X; Liu M; Zhang P; Leung SSY; Xia J
ACS Infect Dis; 2021 Aug; 7(8):2192-2204. PubMed ID: 34232613
[TBL] [Abstract][Full Text] [Related]
11. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
[TBL] [Abstract][Full Text] [Related]
13. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.
Napier BA; Burd EM; Satola SW; Cagle SM; Ray SM; McGann P; Pohl J; Lesho EP; Weiss DS
mBio; 2013 May; 4(3):e00021-13. PubMed ID: 23695834
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.
Yuan Y; Wang L; Li X; Tan D; Cong C; Xu Y
Virus Res; 2019 Oct; 272():197734. PubMed ID: 31465789
[TBL] [Abstract][Full Text] [Related]
16. Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats.
Shivaswamy VC; Kalasuramath SB; Sadanand CK; Basavaraju AK; Ginnavaram V; Bille S; Ukken SS; Pushparaj UN
Microb Drug Resist; 2015 Apr; 21(2):171-7. PubMed ID: 25411824
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii.
Sitthisak S; Manrueang S; Khongfak S; Leungtongkam U; Thummeepak R; Thanwisai A; Burton N; Dhanoa GK; Tsapras P; Sagona AP
Sci Rep; 2023 May; 13(1):7470. PubMed ID: 37156803
[TBL] [Abstract][Full Text] [Related]
18. Isolation and Characterization of a Novel
Wintachai P; Surachat K; Singkhamanan K
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215788
[TBL] [Abstract][Full Text] [Related]
19. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.
Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R
Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028
[TBL] [Abstract][Full Text] [Related]
20. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
